US FDA’s New Drug Median Review Time Held Steady At Eight Months In 2021

 
• By Bridget Silverman
FDA review times are track.
FDA continues to speed through novel drug reviews. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers